List of Tables
Table 1. Global PDE 4 Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global PDE 4 Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global PDE 4 Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global PDE 4 Inhibitors Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global PDE 4 Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global PDE 4 Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global PDE 4 Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market PDE 4 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of PDE 4 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PDE 4 Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PDE 4 Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of PDE 4 Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PDE 4 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PDE 4 Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PDE 4 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global PDE 4 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 18. Global PDE 4 Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global PDE 4 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 20. Global PDE 4 Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global PDE 4 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global PDE 4 Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global PDE 4 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global PDE 4 Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America PDE 4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America PDE 4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 27. North America PDE 4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 28. North America PDE 4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America PDE 4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe PDE 4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe PDE 4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 32. Europe PDE 4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 33. Europe PDE 4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe PDE 4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific PDE 4 Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific PDE 4 Inhibitors Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific PDE 4 Inhibitors Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific PDE 4 Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific PDE 4 Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America PDE 4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America PDE 4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 42. Latin America PDE 4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 43. Latin America PDE 4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America PDE 4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa PDE 4 Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa PDE 4 Inhibitors Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa PDE 4 Inhibitors Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa PDE 4 Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa PDE 4 Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global PDE 4 Inhibitors Sales (K Units) by Type (2020-2025)
Table 51. Global PDE 4 Inhibitors Sales (K Units) by Type (2026-2031)
Table 52. Global PDE 4 Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global PDE 4 Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global PDE 4 Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global PDE 4 Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global PDE 4 Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global PDE 4 Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global PDE 4 Inhibitors Price (US$/Unit) by Type (2020-2025)
Table 59. Global PDE 4 Inhibitors Price (US$/Unit) by Type (2026-2031)
Table 60. Global PDE 4 Inhibitors Sales (K Units) by Application (2020-2025)
Table 61. Global PDE 4 Inhibitors Sales (K Units) by Application (2026-2031)
Table 62. Global PDE 4 Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global PDE 4 Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global PDE 4 Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global PDE 4 Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global PDE 4 Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global PDE 4 Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global PDE 4 Inhibitors Price (US$/Unit) by Application (2020-2025)
Table 69. Global PDE 4 Inhibitors Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer(Anacor) Company Information
Table 71. Pfizer(Anacor) Description and Business Overview
Table 72. Pfizer(Anacor) PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer(Anacor) PDE 4 Inhibitors Product
Table 74. Pfizer(Anacor) Recent Developments/Updates
Table 75. Arcutis Biotherapeutics Company Information
Table 76. Arcutis Biotherapeutics Description and Business Overview
Table 77. Arcutis Biotherapeutics PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Arcutis Biotherapeutics PDE 4 Inhibitors Product
Table 79. Arcutis Biotherapeutics Recent Developments/Updates
Table 80. UNION Therapeutics Company Information
Table 81. UNION Therapeutics Description and Business Overview
Table 82. UNION Therapeutics PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. UNION Therapeutics PDE 4 Inhibitors Product
Table 84. UNION Therapeutics Recent Developments/Updates
Table 85. Innovent Biologics, Inc. Company Information
Table 86. Innovent Biologics, Inc. Description and Business Overview
Table 87. Innovent Biologics, Inc. PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Innovent Biologics, Inc. PDE 4 Inhibitors Product
Table 89. Innovent Biologics, Inc. Recent Developments/Updates
Table 90. Amgen Company Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Amgen PDE 4 Inhibitors Product
Table 94. Amgen Recent Developments/Updates
Table 95. Ralington pharma LLP Company Information
Table 96. Ralington pharma LLP Description and Business Overview
Table 97. Ralington pharma LLP PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Ralington pharma LLP PDE 4 Inhibitors Product
Table 99. Ralington pharma LLP Recent Developments/Updates
Table 100. Beijing Biolab Technology Co., Ltd. Company Information
Table 101. Beijing Biolab Technology Co., Ltd. Description and Business Overview
Table 102. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product
Table 104. Beijing Biolab Technology Co., Ltd. Recent Developments/Updates
Table 105. Nycomed Company Information
Table 106. Nycomed Description and Business Overview
Table 107. Nycomed PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Nycomed PDE 4 Inhibitors Product
Table 109. Nycomed Recent Developments/Updates
Table 110. Forest Company Information
Table 111. Forest Description and Business Overview
Table 112. Forest PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Forest PDE 4 Inhibitors Product
Table 114. Forest Recent Developments/Updates
Table 115. Bristol Myers Company Information
Table 116. Bristol Myers Description and Business Overview
Table 117. Bristol Myers PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Bristol Myers PDE 4 Inhibitors Product
Table 119. Bristol Myers Recent Developments/Updates
Table 120. GSK Company Information
Table 121. GSK Description and Business Overview
Table 122. GSK PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. GSK PDE 4 Inhibitors Product
Table 124. GSK Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. PDE 4 Inhibitors Distributors List
Table 128. PDE 4 Inhibitors Customers List
Table 129. PDE 4 Inhibitors Market Trends
Table 130. PDE 4 Inhibitors Market Drivers
Table 131. PDE 4 Inhibitors Market Challenges
Table 132. PDE 4 Inhibitors Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of PDE 4 Inhibitors
Figure 2. Global PDE 4 Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global PDE 4 Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Rolipram Product Picture
Figure 5. Tetomilast Product Picture
Figure 6. Cilomilast Product Picture
Figure 7. Criborole Product Picture
Figure 8. Apremilast Product Picture
Figure 9. Roflumilast Product Picture
Figure 10. Others Product Picture
Figure 11. Global PDE 4 Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global PDE 4 Inhibitors Market Share by Application: 2024 & 2031
Figure 13. Psoriasis
Figure 14. Chronic Obstructive Pulmonary Disease (COPD)
Figure 15. Asthma
Figure 16. Ankylosing Spondylitis (AS)
Figure 17. Inflammatory Bowel Disease (IBD)
Figure 18. Atopic Dermatitis
Figure 19. Rheumatoid Arthritis (RA)
Figure 20. Systemic Lupus Erythematosus (SLE)
Figure 21. Others
Figure 22. Global PDE 4 Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global PDE 4 Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 24. Global PDE 4 Inhibitors Sales (2020-2031) & (K Units)
Figure 25. Global PDE 4 Inhibitors Average Price (US$/Unit) & (2020-2031)
Figure 26. PDE 4 Inhibitors Report Years Considered
Figure 27. PDE 4 Inhibitors Sales Share by Manufacturers in 2024
Figure 28. Global PDE 4 Inhibitors Revenue Share by Manufacturers in 2024
Figure 29. Global 5 and 10 Largest PDE 4 Inhibitors Players: Market Share by Revenue in PDE 4 Inhibitors in 2024
Figure 30. PDE 4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 31. Global PDE 4 Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 32. North America PDE 4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 33. North America PDE 4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 34. United States PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Canada PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Europe PDE 4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 37. Europe PDE 4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 38. Germany PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. France PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. U.K. PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Italy PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Russia PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Asia Pacific PDE 4 Inhibitors Sales Market Share by Region (2020-2031)
Figure 44. Asia Pacific PDE 4 Inhibitors Revenue Market Share by Region (2020-2031)
Figure 45. China PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Japan PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. South Korea PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. India PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Australia PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. China Taiwan PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Southeast Asia PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Latin America PDE 4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 53. Latin America PDE 4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 54. Mexico PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Brazil PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Argentina PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa PDE 4 Inhibitors Sales Market Share by Country (2020-2031)
Figure 58. Middle East and Africa PDE 4 Inhibitors Revenue Market Share by Country (2020-2031)
Figure 59. Turkey PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. Saudi Arabia PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. UAE PDE 4 Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 62. Global Sales Market Share of PDE 4 Inhibitors by Type (2020-2031)
Figure 63. Global Revenue Market Share of PDE 4 Inhibitors by Type (2020-2031)
Figure 64. Global PDE 4 Inhibitors Price (US$/Unit) by Type (2020-2031)
Figure 65. Global Sales Market Share of PDE 4 Inhibitors by Application (2020-2031)
Figure 66. Global Revenue Market Share of PDE 4 Inhibitors by Application (2020-2031)
Figure 67. Global PDE 4 Inhibitors Price (US$/Unit) by Application (2020-2031)
Figure 68. PDE 4 Inhibitors Value Chain
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
